FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development June 24, 2025July 9, 2025 Share More from the Blog The Path to Productivity: Tackling the Crisis in Drug Development using Improved Preclinical Models Read More Investigating key mechanisms of Parkinson’s with an αSyn fibril-induced brain-on-a-chip model Read More Predictive Validity: the Key to Improving the Drug Development Process Read More Browse All